Earnings Alerts

Verallia (VRLA) Earnings: FY Adjusted EBITDA Meets Estimates at €842.5M, Revenue Slightly Misses

By February 20, 2025 No Comments
“`html

  • Verallia‘s adjusted EBITDA for the fiscal year was reported at €842.5 million, which aligns closely with the estimated €839.4 million.
  • The company’s total revenue for the fiscal year was €3.46 billion, slightly below the estimate of €3.48 billion.
  • The dividend per share announced is €1.70, just under the projected €1.72.
  • Analyst recommendations for Verallia include 9 buy ratings, 3 hold ratings, and no sell ratings.

“`


A look at Verallia Smart Scores

FactorScoreMagnitude
Value2
Dividend5
Growth4
Resilience2
Momentum2
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Verallia, a company that specializes in manufacturing and distributing packaging products such as glass bottles and containers, shows a mixed long-term outlook based on Smartkarma Smart Scores. While the company ranks high in Dividend and Growth scores, indicating strong performance in these areas, it lags behind in Value, Resilience, and Momentum scores. This suggests that Verallia may offer good returns to investors in terms of dividends and growth potential, but factors like value, resilience in adverse conditions, and momentum in the market could be areas of concern.

In summary, Verallia is a global player in the packaging industry, known for its wide range of glass packaging solutions for food, beverages, and liquids. With a focus on delivering dividends and fostering growth, the company positions itself well in these aspects according to the Smartkarma Smart Scores. However, attention may be needed to enhance its value proposition, resilience to market fluctuations, and momentum to stay competitive in the long run.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars